美国食品和药物管理局计划逐步取消在感冒药中的使用, FDA plans to phase out phenylephrine in cold medicines due to its ineffectiveness.

FDA 计划逐步淘汰去氧肾上腺素，去氧肾上腺素是 Sudafed 和 Dayquil 等流行感冒药中的一种减充血剂，因为它在缓解鼻塞方面无效。 The FDA plans to phase out phenylephrine, a decongestant in popular cold medicines like Sudafed and Dayquil, due to its ineffectiveness in relieving nasal congestion. 这一决定是在研究后作出的,研究表明苯丙胺并不比安慰剂好。 This decision follows studies showing phenylephrine is no better than a placebo. 药物制造商可能需要删除或改制产品。 Drug manufacturers may need to remove or reformulate products. 医生推荐替代品,如盐水冲洗液、氟菊菊酯等鼻涕类固醇,以及抗脊髓灰质炎喷雾等,以缓解疾病。 Doctors recommend alternatives such as saline rinses, nasal steroids like Flonase, and antihistamine sprays for relief.